These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12368684)

  • 1. Summary of symposium: the future of stem cell transplantation for sickle cell disease.
    Woodard P; Jeng M; Handgretinger R; Wang W; Cunningham J
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):512-4. PubMed ID: 12368684
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on "Summary of Symposium: The Future of Stem Cell Transplantation for Sickle Cell Disease".
    Iannone R; Chen AR; Casella JF
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):515-7. PubMed ID: 12368685
    [No Abstract]   [Full Text] [Related]  

  • 3. Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease.
    Janakiram M; Verma A; Wang Y; Budhathoki A; Suarez Londono J; Murakhovskaya I; Braunschweig I; Minniti CP
    Leuk Lymphoma; 2018 Jan; 59(1):241-244. PubMed ID: 28587497
    [No Abstract]   [Full Text] [Related]  

  • 4. Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
    Hoppe C; Neumayr L
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):355-371. PubMed ID: 31030807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options.
    Amrolia PJ; Almeida A; Halsey C; Roberts IA; Davies SC
    Br J Haematol; 2003 Mar; 120(5):725-36. PubMed ID: 12614202
    [No Abstract]   [Full Text] [Related]  

  • 6. Principles and indications of chronic transfusion therapy for children with sickle cell disease.
    Ware R
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409
    [No Abstract]   [Full Text] [Related]  

  • 7. Iatrogenic Infertility After Curative Stem Cell Transplantation in Patients With Sickle Cell Disease.
    Mishkin AD; Mapara MY; Reshef R
    Ann Intern Med; 2018 Jun; 168(12):881-882. PubMed ID: 29710348
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in management of sickle cell disease.
    Agarwal MB
    Indian J Pediatr; 2003 Aug; 70(8):649-54. PubMed ID: 14510086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease.
    Fixler J; Styles L
    Pediatr Clin North Am; 2002 Dec; 49(6):1193-210, vi. PubMed ID: 12580362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
    Abraham A; Cluster A; Jacobsohn D; Delgado D; Hulbert ML; Kukadiya D; Murray L; Shenoy S
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1587-1592. PubMed ID: 28578010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell anaemia: current therapies.
    Vermylen C
    Transfus Apher Sci; 2013 Oct; 49(2):151-4. PubMed ID: 23954416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematology clinic. Sickle cell disease.
    Ngo D; Steinberg M
    Hematology; 2014 Jun; 19(4):244-5. PubMed ID: 24666152
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry.
    Gilmore A; Cho G; Howard J; Layton M; Afif M; Hughes RG; Philpott NJ; Patankar S; Davies SC;
    Am J Hematol; 2011 Nov; 86(11):958-61. PubMed ID: 21948113
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence gaps in the management of sickle cell disease: A summary of needed research.
    Savage WJ; Buchanan GR; Yawn BP; Afenyi-Annan AN; Ballas SK; Goldsmith JC; Hassell KL; James AH; John-Sowah J; Jordan L; Lottenberg R; Murad MH; Ortiz E; Tanabe PJ; Ware RE; Lanzkron SM
    Am J Hematol; 2015 Apr; 90(4):273-5. PubMed ID: 25639238
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary of the 12th international symposium on recent advances in stem cell transplantation.
    Ball ED; Ho AD
    Exp Hematol; 2004 Oct; 32(10):881-4. PubMed ID: 15504542
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells as future therapy in cardiology.
    Lindsay AC; Halcox JP
    Hosp Med; 2005 Apr; 66(4):215-20. PubMed ID: 15889869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease in children.
    Wang WC
    Clin Adv Hematol Oncol; 2011 Jul; 9(7):554-6. PubMed ID: 22402464
    [No Abstract]   [Full Text] [Related]  

  • 19. First report of successful stem cell transplantation in a patient with sickle cell hemoglobin D disease.
    Hamidieh AA; Jalili M; Khojasteh O; Ghavamzadeh A
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):397-9. PubMed ID: 20502357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles.
    Lukusa AK; Vermylen C; Vanabelle B; Curaba M; Brichard B; Chantrain C; Dupont S; Ferrant A; Wyns C
    Pediatr Hematol Oncol; 2009 Jun; 26(4):186-94. PubMed ID: 19437321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.